ENTRY       D10064                      Drug
NAME        Dabrafenib (USAN)
FORMULA     C23H20F3N5O2S2
EXACT_MASS  519.1011
MOL_WEIGHT  519.5624
CLASS       Antineoplastic
             DG03159  BRAF inhibitor
            Metabolizing enzyme substrate
             DG02918  CYP2C8 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
            Metabolizing enzyme inducer
             DG02886  CYP2C9 inducer
             DG02853  CYP3A/CYP3A4 inducer
              DG01635  CYP3A4 inducer
REMARK      ATC code: L01EC02
            Chemical structure group: DG00721
            Product (DG00721): D10104<JP/US>
EFFICACY    Antineoplastic, BRAF kinase inhibitor
TARGET      BRAF [HSA:673] [KO:K04365]
  PATHWAY   hsa04010(673)  MAPK signaling pathway
            hsa04012(673)  ErbB signaling pathway
            hsa05200(673)  Pathways in cancer
METABOLISM  Enzyme: CYP3A4 [HSA:1576], CYP2C8 [HSA:1558]
INTERACTION CYP induction: CYP3A4 [HSA:1576], CYP2C9 [HSA:1559]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01E PROTEIN KINASE INHIBITORS
                L01EC B-Raf serine-threonine kinase (BRAF) inhibitors
                 L01EC02 Dabrafenib
                  D10064  Dabrafenib (USAN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG03159  BRAF inhibitor
               DG00721  Dabrafenib
                D10064  Dabrafenib
             Metabolizing enzyme substrate
              DG02918  CYP2C8 substrate
               DG00721  Dabrafenib
                D10064  Dabrafenib
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00721  Dabrafenib
                 D10064  Dabrafenib
             Metabolizing enzyme inducer
              DG02886  CYP2C9 inducer
               DG00721  Dabrafenib
                D10064  Dabrafenib
              DG02853  CYP3A/CYP3A4 inducer
               DG01635  CYP3A4 inducer
                DG00721  Dabrafenib
                 D10064  Dabrafenib
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Serine/threonine kinases
               TKL group
                BRAF
                 D10064  Dabrafenib (USAN)
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D10064
            Drug groups [BR:br08330]
             Antineoplastic
              DG03159  BRAF inhibitor
               DG00721  Dabrafenib
             Metabolizing enzyme substrate
              DG02918  CYP2C8 substrate
               DG00721  Dabrafenib
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00721  Dabrafenib
             Metabolizing enzyme inducer
              DG02886  CYP2C9 inducer
               DG00721  Dabrafenib
              DG02853  CYP3A/CYP3A4 inducer
               DG01635  CYP3A4 inducer
                DG00721  Dabrafenib
DBLINKS     CAS: 1195765-45-7
            PubChem: 135626784
            ChEBI: 75045
            PDB-CCD: P06
            LigandBox: D10064
ATOM        35
            1   C8y C    26.9500  -34.2300
            2   C8y C    26.9500  -35.6300
            3   C8x C    28.1624  -36.3300
            4   C8x C    29.3749  -35.6300
            5   C8x C    29.3749  -34.2300
            6   C8y C    28.1624  -33.5300
            7   X   F    28.1624  -32.1302
            8   X   F    25.7376  -36.3300
            9   S4a S    25.7376  -33.5300
            10  N1b N    24.5421  -34.2204
            11  C8y C    23.3547  -33.5349
            12  C8x C    23.3546  -32.1302
            13  C8x C    22.1421  -31.4303
            14  C8x C    20.9297  -32.1304
            15  C8y C    20.9298  -33.5351
            16  C8y C    22.1423  -34.2350
            17  X   F    22.1424  -35.6298
            18  C8y C    19.7198  -34.2339
            19  N5x N    18.5913  -33.4297
            20  C8y C    17.4817  -34.2554
            21  S2x S    17.9241  -35.5658
            22  C8y C    19.3071  -35.5500
            23  C8y C    20.1516  -36.6862
            24  C8x C    19.4315  -37.8755
            25  C8x C    20.1072  -39.1017
            26  N5x N    21.5069  -39.1296
            27  C8y C    22.2263  -37.9391
            28  N5x N    21.5506  -36.7130
            29  C1d C    16.1552  -33.8409
            30  C1a C    15.1487  -34.7675
            31  C1a C    15.8425  -32.4488
            32  C1a C    14.8029  -33.4785
            33  N1a N    23.6597  -37.9677
            34  O3c O    24.7477  -32.5401
            35  O3c O    26.7275  -32.5401
BOND        38
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     6   7 1
            8     2   8 1
            9     1   9 1
            10    9  10 1
            11   10  11 1
            12   11  12 2
            13   12  13 1
            14   13  14 2
            15   14  15 1
            16   15  16 2
            17   11  16 1
            18   16  17 1
            19   15  18 1
            20   18  19 1
            21   19  20 2
            22   20  21 1
            23   21  22 1
            24   18  22 2
            25   22  23 1
            26   23  24 1
            27   24  25 2
            28   25  26 1
            29   26  27 2
            30   27  28 1
            31   23  28 2
            32   20  29 1
            33   29  30 1
            34   29  31 1
            35   29  32 1
            36   27  33 1
            37    9  34 2
            38    9  35 2
///
